GT Biopharma
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has GT Biopharma's balance sheet done over the years? Its assets were worth $14,109,000 last year, which is less than in the previous period. 47% of GT Biopharma’s total assets is currently financed by debt. Its liabilities reached the amount of $6,633,000, which means an increase by 33% compared compared to last year.
Debt to Assets
| 2014 | 888000 | 30.46M | 3430.41% |
|---|---|---|---|
| 2015 | 54000 | 61.88M | 114607.41% |
| 2016 | 25000 | 18.94M | 75796% |
| 2017 | 254368000 | 2.67M | 1.05% |
| 2018 | 25399000 | 14.02M | 55.23% |
| 2019 | 396000 | 19.70M | 4976.26% |
| 2020 | 5661000 | 35.09M | 619.93% |
| 2021 | 32169000 | 10.25M | 31.89% |
| 2022 | 16736000 | 5.00M | 29.89% |
| 2023 | 14109000 | 6.63M | 47.01% |
GTBP Balance Sheet (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 1.07M | 5.67M | 8.96M | 5.29M | 28K | 60K | 576K | 19K | 47K | 855K |
Short term investments | 12.89M | 10.83M | 23.01M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other current assets | 84K | 54K | 190K | 364K | 246K | 30K | 0 | 2K | 2K | 27K |
Total current assets | 14.05M | 16.56M | 32.16M | 5.66M | 274K | 90K | 576K | 21K | 49K | 882K |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 53K | 165K | 0 | 0 | 110K | 35K | 6K | 4K | 5K | 6K |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible assets | 0 | 0 | 0 | 0 | 0 | 25.26M | 253.77M | 0 | 0 | 0 |
Long term investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current assets | 0 | 9K | 0 | 0 | 12K | 12K | 9K | 0 | 0 | 0 |
Total non-current assets | 53K | 174K | 0 | 0 | 122K | 25.30M | 253.79M | 4K | 5K | 6K |
Total assets | 14.10M | 16.73M | 32.16M | 5.66M | 396K | 25.39M | 254.36M | 25K | 54K | 888K |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 0 | 0 | 1.90M | 6.13M | 0 | 0 | 0 | 4.01M | 6.71M | 5.11M |
Short term debt | 116K | 110K | 31K | 26.33M | 13.35M | 10.80M | 31K | 12.41M | 9.03M | 2.72M |
Total current liabilities | 6.63M | 4.93M | 10.25M | 35.09M | 19.70M | 14.02M | 2.67M | 18.94M | 61.17M | 29.82M |
| Non-current liabilities: | ||||||||||
Long term debt | 0 | 64K | 0 | 0 | 0 | 0 | 0 | 0 | 714K | 634K |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total non-current liabilities | 0 | 64K | 0 | 0 | 0 | 0 | 0 | 0 | 714K | 634K |
Total liabilities | 6.63M | 5.00M | 10.25M | 35.09M | 19.70M | 14.02M | 2.67M | 18.94M | 61.88M | 30.46M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |